Chris M. Pillar

In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains

Karen Joy Shaw, Susan M. Poppe, Ronda D. Schaadt et al. · Antimicrobial Agents and Chemotherapy · 2008 · 180 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Monitoring Antibiotic Resistance in Ocular Microorganisms: Results From the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 Surveillance Study

Wolfgang Haas, Chris M. Pillar, Mohana Torres et al. · American Journal of Ophthalmology · 2011 · 158 citations

Medicine, Microbiology, Ophthalmology +15

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents

Leslie W. Tari, Xiaoming Li, Michael Trzoss et al. · PLoS ONE · 2013 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria

Wolfgang Haas, Chris M. Pillar, Gary E. Zurenko et al. · Antimicrobial Agents and Chemotherapy · 2009 · 102 citations · Full text

Medicine, Microbiology, Ophthalmology +16

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09

Todd A. Davies, Anne Marie Queenan, Brian J. Morrow et al. · Journal of Antimicrobial Chemotherapy · 2011 · 99 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17